Bell Laboratories promoted Patrick Lynch, ACE, to chief operating officer, effective July 1, 2026. In his new role, Lynch has manufacturing operations, research and development, and engineering as added responsibilities to his current oversight of the sales and marketing functions.
“Patrick has been a major contributor to Bell’s success for the past 20 years,” said Steve Levy, Bell Laboratories president and CEO, and a member of the Pest Management Professional (PMP) Hall of Fame (Class of 2022). “Throughout his tenure, he has demonstrated exceptional leadership, a deep commitment to our customers and employees, and a consistent ability to deliver results. As Bell continues to grow and evolve, Pat’s experience and leadership will play a critical role in helping us execute our strategic objectives and build on the strong foundation that has been established.”
A respected leader within the pest management industry, Lynch currently serves as president of the United Producers, Formulators and Distributors Association (UPFDA). A former member of the National Pest Management Association (NPMA) board of directors, he serves on the association’s Public Policy Committee, Workforce Development Steering Committee, and the P3 Strategic Planning Committee.
About Bell Laboratories
Based in Windsor, Wis., and founded in 1975 by Pest Management Professional Hall of Famer Malcolm Stack (Class of 2004), Bell Laboratories produces high-quality rodenticides and other rodent control products for the pest control and agricultural industries across six continents. Bell’s complete line of products — rodenticides, tamper-resistant bait stations, smart rodent monitoring devices, glue boards, mechanical traps and attractants — control rodents in any situation. These products are combined with technical expertise, manufacturing capabilities and superior service.
<p>The post Bell promotes Lynch to COO first appeared on Pest Management Professional.</p>
from Pest Management Professional https://www.mypmp.net/bell-promotes-lynch-to-coo/
Sacramento CA
No comments:
Post a Comment